Top Markets
#1 Palladium Network Palladium Network +19.88%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.80%
#3 OpenEden OpenEden +13.40%
#4 MarsCoin MarsCoin +12.48%
#5 clBTC clBTC +12.08%
#6 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.74%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.57%
#8 Mantle Staked Ether Mantle Staked Ether +8.34%
#9 Mantle Restaked ETH Mantle Restaked ETH +8.01%
#10 Kinesis Silver Kinesis Silver +6.47%
Coin of the day
Palladium Network Palladium Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Synairgen plc Synairgen plc

Synairgen plc

SNG
Classifica tra le azioni #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Prezzo delle azioni
$0.01292666
Ultima sincronizzazione: 2025-04-08
Capitalizzazione di mercato
$157.54K
Variazione (1 giorno)
6.84%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Synairgen plc (SNG)

Categoria

Healthcare
Storico del prezzo dell'azione per Synairgen plc (SNG)
Prezzo di chiusura più alto: $0.01 il 2025-04-01

Prezzo di chiusura più basso: $2.04 il 2004-10-01
Storico del prezzo dell'azione di Synairgen plc dal 2004 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 -66.26%
2024 -44.21%
2023 -52.93%
2022 -92.61%
2021 77.16%
2020 1,567.16%
2019 -48.13%
2018 14.84%
2017 -14.89%
2016 -49.84%
2015 -35.02%
2014 -37.63%
2013 15.10%
2012 50.92%
2011 14.84%
2010 -28.85%
2009 88.33%
2008 -77.12%
2007 -24.86%
2006 -99.32%
2005 209.00%
2004 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.09%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE